Author | Year | Country | Study design | Serum Vitamin D concentration before / after supplementary (ng/ml) | Recruited patients number | Treatment(s) | Control | Fertilization | Disease | Duration of Vitamin D supplement | |
---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | ||||||||||
Abedi | 2019 | Iran | Double-Blind Randomized Placebo-Controlled Trial | 13.6 ± 6.6/37.1 ± 7.7 vs 12.7 ± 6.4/14.4 ± 6.6 | 54 | 54 | Vitamin D | placebo | ICSI | Infertile couples who had Vitamin D level below 30 ng/ml without symptom of Vitamin D deficiency | Six weeks |
Aflatoonian | 2014 | Iran | Randomized controlled trial | below 30 | 57 | 57 | Vitamin D | – | IVF/ICSI | Infertile women undergo IVF/ICSI | Six-eight weeks |
Doryanizadeh | 2021 | Iran | Double-Blind Randomized Clinical Trial | 27.5 ± 1.8 vs 27.6 ± 1.8 | 51 | 44 | Calcitriol (Vitamin D3) | placebo | – | Infertile women | Four weeks |
Espinola | 2021 | Italy | Randomized and controlled pilot study | 25.4 (6.7; 16.0–40.0)/33.2(4.3; 23.3–40.4) vs 23.9 (4.9; 14.0–35.6) /24.3(5.2; 16.1–36.4) | 60 | 60 | Myo-Inositol (600 mg), folic acid (200 mg), melatonin (1.0 mg) and vitamin D3 (50 μg, 2000 IU) as cholecalciferol | Myo-Inositol (600 mg), folic Acid (200 mg), melatonin (1.0 mg), folic acid (200 μg) | – | Infertile women of different etiology | From the day of hCG administration until 14 days after embryo transfer |
Fatemi | 2017 | Iran | Double-Blind Randomized Placebo-Controlled Trial | below 30 | 52 | 53 | Vitamin E, 400 mg/day dl alpha tocopherylacetate and vitamin D3 | placebo | ICSI | PCOS | Eight weeks |
Kermack | 2019 | United Kingdom | Double-blinded randomized controlled trial | 74.33 ± vs 71.62 ± 24.69 nmol/L/ 154.63 ± 1.56 nmol/L vs. 68.50 ± 1.51 | 55 | 56 | EPA(800 mg), DHA (1200 mg), or vitamin D in olive oil | Sunflower seed oil | IVF or IVF-ICSI | Women undergoing IVF | Six weeks |
Lan | 2018 | China | Clinical trial | below 30 | 37 | 37 | Vitamin D2 | – | – | Infertile women who had failed to undergo IVF fresh embryo transplantation | Six weeks at least |
Somigliana | 2021 | Italy | Randomized superiority double-blind placebo controlled clinical trial | 20.0(15.5–23.6) vs 19.9(14.6–23.9) | 308 | 322 | Vitamin D3 diluted in olive oil | placebo (the olive oil) | Classical IVF and ICSI | Women undergoing IVF | A single administration |
Tang | 2017 | China | Randomized controlled trial | – | 235 | 155 | Multivitamin tablets (elevit)pearl/daily orally | – | IVF-ET | Infertile women | Ninety days |
Wdowiak | 2020 | Poland | Randomized controlled trial | – | 50 | 50 | 600 mg MI, 200 μg folic acid, 1 mg melatonin, 50 μg equivalent to 2000 IU vitamin D3 | placebo | ICSI | Infertile women | Three months |
Zhao | 2019 | China | Clinical trial | – | 190 | 115 | 25OH-VD | – | – | PCOS and insulin resistance | Two-three months |
Zhuang | 2019 | China | Clinical trial | – | 204 | 192 | Vitamin D combined with metformin and clomiphene | metformin and clomiphene | – | Patients with PCOS combined with infertility | Three consecutive menstrual cycles |
Author | Administration frequency of Vitamin D | Total Vitamin D dosage (IU) | Administration route | Age (years) | BMI (kg/m2) | Duration of infertility | Transfer type | Stage of embryo | Outcome measures |
---|---|---|---|---|---|---|---|---|---|
Abedi | 50,000 units/week | 300,000 | Oral administration | 18–38(31.9 ± 4.2/30.8 ± 4.4) | 18–30(23.9 ± 2.1/23.8 ± 1.9) | 77.4 ± 22.1/68.1 ± 19.3 months | – | – | Biochemical and clinical pregnancy rate |
Aflatoonian | 50,000/week | 300,000-400,000 | Oral administration | 28.45 ± 3.74/29.56 ± 4.68 | 26.87 ± 1.77/26.29 ± 1.67 | – | Frozen embryo transfer | Embryos A/B/C | Biochemical and clinical pregnancy rate |
Doryanizadeh | Two 0.25 μg daily | 560 | Oral administration | 20–40(32.5 ± 4.9/31.6 ± 4.9) | 25.3 ± 3.2/24.9 ± 3.4 | 7.0 ± 4.7/7.1 ± 4.8 years | Frozen embryo transfer | – | Biochemical and clinical pregnancy rate, miscarriage rate and pregnancy continued until week 20 |
Espinola | 50 μg, 2000 IU daily | 42,000 | Oral administration | ≤ 42[34.7 (6.7;22–42)/35.9 (3.7;27.0–42.0)] | 18.5–24.9[21.9 (2.1;17.6–28.4)/22.0 (2.3;17.6–27.5)] | 3.7 (1.8;1.0–9.0)/3.6 (2.1;1.0–10.0) years | Fresh embryo transfer | Blastocysts graded A/B | Implantation rate, Biochemical and clinical pregnancy rate, miscarriage rate, multiple pregnancy rate |
Fatemi | 50,000 IU/one in two weeks-3300 IU/daily | 200,000 | Oral administration | 18–38(28.07 ± 4.21/28.13 ± 3.73) | 20–34(26.53 ± 2.99/26.13 ± 3.58) | 61.61 ± 43.62/66.46 ± 36.31 months | Fresh and frozen embryo transfer | Embryo with good morphologic | Implantation rate, Biochemical and clinical pregnancy rate, multiple pregnancy rate |
Kermack | 10 μg, 400 IU daily | 16,800 | Oral administration | 18–41(33.3 ± 4.1/33.4 ± 4.3) | 18–32(24.3 ± 3.1/25.0 ± 3.9) | – | – | Embryo with highest morphologic score | Implantation, clinical pregnancy and live bith rate |
Lan | 10 ml (50 mg)/one time in two weeks | 45,000 | Intramuscular injection | – | – | – | Frozen embryos | – | Implantation and clinical pregnancy rate |
Somigliana | 600,000 IU | 600,000 | Oral administration | 18–39[35.0(32.0–37.0)/35.0(33.0–37.0)] | 18–25[20.8(19.5–22.5)/21.1(19.7–22.9)] | 3(2–4)/2.5(2–4) years | Fresh and frozen embryos | Blastocyst Stage (Day 5) | Biochemical and clinical pregnancy rate, miscarriage rate, multiple pregnancy rate and live birth rate |
Tang | Vitamin D 500 IU/daily | 45,000 | Oral administration | 24–43(32.5 ± 3.2)/23–42(31.8 ± 3.0) | – | 1–12(4.2 ± 1.4)/1–11(4.0 ± 1.2) years | – | – | Clinical pregnancy, and miscarriage rate |
Wdowiak | 50 μg equivalent to 2000 IU vitamin D3 as cholecalciferol/daily | 168,000 | Oral administration | 20–35(31 ± 3.11/31.2 ± 3.03) | 24.76 ± 2.94/25.11 ± 2.39 | – | – | – | Clinical pregnancy rate |
Zhao | – | – | – | 31.2 ± 4.3/32.1 ± 4.2,32.0 ± 3.4/31.6 ± 6.9 | 22.4 ± 2.4/24.7 ± 4.7, 23.5 ± 3.8/24.1 ± 4.4 | 3.8 ± 2.3/3.1 ± 3.2,3.7 ± 1.0/3.4 ± 2.2 | Frozen embryos | – | Implantation and clinical pregnancy rate |
Zhuang | 3000 IU daily, 5 days/menstrual cycle | 45,000 | Oral administration | 26.33 ± 4.05/25.64 ± 4.78 | 27.53 ± 4.13/27.28 ± 3.56 | 3.87 ± 2.44/3.52 ± 2.56 | – | – | Pregnancy rate |